Поисковый запрос: (<.>S=ВОРИКОНАЗОЛ<.>) |
Общее количество найденных документов : 214
Показаны документы с 1 по 20
|
|
1.
| The effect of the new triazole, voriconazole (UK-109, 496), on the interactions of Candida albicans and Candida krusei with endothelial cells // J. Chemother., 1998. Vol. 10, N 1.-С.7-16
|
2.
| The effect of the new triazole, voriconazole (UK-109, 496), on the interactions of Candida albicans and Candida krusei with endothelial cells // J. Chemother., 1998. Vol. 10, N 1.-С.7-16
|
3.
| Активность in vitro вориконазола (UK-109.496) и четырех других противогрибковых препаратов в отношении 394 клинических штаммов Candida spp. // Антибиотики и химиотерапия, 1998. Т. 43, N 12.-С.39-40
|
4.
| Активность in vitro вориконазола (UK-109.496) и четырех других противогрибковых препаратов в отношении 394 клинических штаммов Candida spp. // Антибиотики и химиотерапия, 1998. Т. 43, N 12.-С.39-40
|
5.
| Kappe R. Mycological aspects of in vitro activity of voriconazole // Mycoses, 1999. Vol. 42, N 3.-С.139
|
6.
| Kauffman Carol A. Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species // Mycoses, 1999. Vol. 42, N 9-10.-С.539-542
|
7.
| Kauffman Carol A. Colorimetric method for susceptibility testing of voriconazole and other triazoles against Candida species // Mycoses, 1999. Vol. 42, N 9-10.-С.539-542
|
8.
| Kappe R. Mycological aspects of in vitro activity of voriconazole // Mycoses, 1999. Vol. 42, N 3.-С.139
|
9.
| Kappe R. Antifungal activity of the new azole UK-109, 496 (voriconazole) // Mycoses, 1999. Vol. 42, Suppl. 2.-С.83-86
|
10.
| Kappe R. Antifungal activity of the new azole UK-109, 496 (voriconazole) // Mycoses, 1999. Vol. 42, Suppl. 2.-С.83-86
|
11.
| Meningitis caused by Pseudallescheria boydii treated with voriconazole // Clin. Infec. Diseases, 2000. Vol. 30, N 6.-С.981-982
|
12.
| Meningitis caused by Pseudallescheria boydii treated with voriconazole // Clin. Infec. Diseases, 2000. Vol. 30, N 6.-С.981-982
|
13.
| Ernst Erika J. Investigational antifungal agents // Pharmacotherapy, 2001. Vol. 21, N 8.-С.165-174
|
14.
| In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592) // Mycoses, 2002. Vol. 45, N 9-10.-С.378-383
|
15.
| In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592) // Mycoses, 2002. Vol. 45, N 9-10.-С.378-383
|
16.
| Bernhardt Changes in Candida albicans colonization and morphology under influence of voriconazole // Mycoses, 2003. Vol. 46, N 9-10.-С.370-374
|
17.
| Comparison of etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole // J. Clin. Microbiol., 2003. Vol. 41, N 11.-С.5270-5272
|
18.
| Hyland Identification of the enzymes involved in the N-oxidation of voriconazole // Drug Metab. Rev., 2002. Vol. 34, прил. 1.-С.51
|
19.
| Comparison of etest with modified broth microdilution method for testing susceptibility of Aspergillus spp. to voriconazole // J. Clin. Microbiol., 2003. Vol. 41, N 11.-С.5270-5272
|
20.
| Hyland R. Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole // Drug Metab. and Dispos., 2003. Vol. 31, N 5.-С.540-547
|
&uf('+1W2226#',v2226), ?>
|
|